Lucid Diagnostics Inc. Share-based Payment Arrangement, Expense
Lucid Diagnostics Inc. (LUCD) reported Share-based Payment Arrangement, Expense of $1.69 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-12
- Lucid Diagnostics Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $1.69M, a 48.21% increase year-over-year.
- Lucid Diagnostics Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $1.41M, a 36.99% increase year-over-year.
- Lucid Diagnostics Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $1.17M, a 0.51% decline year-over-year.
- Lucid Diagnostics Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $1.15M, a 6.19% decline year-over-year.
- Lucid Diagnostics Inc. share-based payment arrangement, expense for fiscal 2025 was $4.49M, a 0.95% decline from fiscal 2024.
- Lucid Diagnostics Inc. share-based payment arrangement, expense for fiscal 2024 was $4.53M, a 33.54% decline from fiscal 2023.
- Lucid Diagnostics Inc. share-based payment arrangement, expense for fiscal 2023 was $6.82M, a 54.49% decline from fiscal 2022.
- Lucid Diagnostics Inc. share-based payment arrangement, expense for fiscal 2022 was $14.99M, a 56.17% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.69M 10-Q · filed 2026-08-12 | $3.10M 10-Q · filed 2026-08-12 | $4.27M derived: sum of 3 quarters · filed 2026-08-12 | $5.42M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $1.41M 10-Q · filed 2026-05-13 | $2.58M derived: sum of 2 quarters · filed 2026-05-13 | $3.73M derived: sum of 3 quarters · filed 2026-05-13 | $4.87M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $2.32M derived: sum of 2 quarters · filed 2026-03-25 | $3.46M derived: sum of 3 quarters · filed 2026-08-12 | $4.49M 10-K · filed 2026-03-25 |
| 2025-09-30 | $1.15M 10-Q · filed 2025-11-12 | $2.29M derived: sum of 2 quarters · filed 2026-08-12 | $3.33M 10-Q · filed 2025-11-12 | $4.50M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $1.14M 10-Q · filed 2026-08-12 | $2.17M 10-Q · filed 2026-08-12 | $3.34M derived: sum of 3 quarters · filed 2026-08-12 | $4.57M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $1.03M 10-Q · filed 2026-05-13 | $2.20M derived: sum of 2 quarters · filed 2026-05-13 | $3.43M derived: sum of 3 quarters · filed 2026-05-13 | $4.63M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $2.40M derived: sum of 2 quarters · filed 2026-03-25 | $3.60M derived: sum of 3 quarters · filed 2026-03-25 | $4.53M 10-K · filed 2026-03-25 |
| 2024-09-30 | $1.23M 10-Q · filed 2025-11-12 | $2.43M derived: sum of 2 quarters · filed 2025-11-12 | $3.36M 10-Q · filed 2025-11-12 | $4.33M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $1.20M 10-Q · filed 2025-08-12 | $2.13M 10-Q · filed 2025-08-12 | $3.10M derived: sum of 3 quarters · filed 2025-08-12 | $4.35M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $933.00K 10-Q · filed 2025-05-13 | $1.90M derived: sum of 2 quarters · filed 2025-05-13 | $3.15M derived: sum of 3 quarters · filed 2025-05-13 | $4.55M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $963.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $2.21M derived: sum of 2 quarters · filed 2025-03-24 | $3.61M derived: sum of 3 quarters · filed 2025-03-24 | $6.82M 10-K · filed 2025-03-24 |
| 2023-09-30 | $1.25M 10-Q · filed 2024-11-12 | $2.65M derived: sum of 2 quarters · filed 2024-11-12 | $5.86M 10-Q · filed 2024-11-12 | $9.60M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.40M 10-Q · filed 2024-08-12 | $4.61M 10-Q · filed 2024-08-12 | $8.35M derived: sum of 3 quarters · filed 2024-08-12 | $11.92M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $3.21M 10-Q · filed 2024-05-13 | $6.95M derived: sum of 2 quarters · filed 2024-05-13 | $10.52M derived: sum of 3 quarters · filed 2024-05-13 | $14.36M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $3.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $7.31M derived: sum of 2 quarters · filed 2024-03-25 | $11.15M derived: sum of 3 quarters · filed 2024-03-25 | $14.99M 10-K · filed 2024-03-25 |
| 2022-09-30 | $3.57M 10-Q · filed 2023-11-13 | $7.42M derived: sum of 2 quarters · filed 2023-11-13 | $11.25M 10-Q · filed 2023-11-13 | $14.69M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $3.84M 10-Q · filed 2023-08-14 | $7.68M 10-Q · filed 2023-08-14 | $11.12M derived: sum of 3 quarters · filed 2023-08-14 | $13.89M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $3.83M 10-Q · filed 2023-05-15 | $7.28M derived: sum of 2 quarters · filed 2023-05-15 | $10.05M derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | $3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $6.21M derived: sum of 2 quarters · filed 2023-03-14 | $9.60M 10-K · filed 2023-03-14 | |
| 2021-09-30 | $2.77M 10-Q · filed 2022-11-14 | $6.16M 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |